Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Continuation Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

NCT00285675 is registered in ClinicalTrials.gov with Novacea as lead sponsor.

NCT NCT00285675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00285675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Continuation Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
Lead sponsor
Novacea
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2006
Completion date
January 31, 2008
Enrollment
25
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

androgen independent prostate cancer (aipc), non small cell lung cancer (nsclc)